ADVFN Logo ADVFN

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

MXC Mgc Pharmaceuticals Limited

22.00
0.00 (0.00%)
28 Mar 2025 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 30 June 2024 20172018201920202021202220232024
AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)AUD (AUD)
Total Revenue 120k316k988k2.75M3.85M4.74M4.16M3.02M
Operating Income -8.37M-8.93M-10.72M-17M-11.8M-19.4M-18.14M-16.64M
Pre Tax Income -8.5M-8.99M-11.03M-19.37M-15.9M-20.77M-21.13M-17.55M
Net Income -8.14M-8.25M-8.58M-19.36M-15.87M-20.35M-20.82M-17.53M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.7-0.7-0.7-1.2-0.7-0.7-0.6-38.7
EBIT -8.37M-8.93M-10.72M-17M-11.8M-19.4M-18.14M-16.64M
EBITDA -8.29M-8.61M-8.45M-11.4M-11.31M-14.17M-14.24M-15.35M

Your Recent History

Delayed Upgrade Clock